BMEA Biomea Fusion, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 5, 2026
$1.27
· of 52w range
· above low
· to high
$0.8752w low
$2.9952w high
Market Cap (MRQ)
$92M
P/E
-1.1
EPS
$-1.18
your badges
52W Range
$1–$3
Analyst Rating
BUY
Price Target
$6
P/E
-1.1
ROE
-216.6%
Net Profit Margin
-3326.0%
Your badge strip is empty — pin a metric anywhere on this page.
BMEA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.27
Market Cap (MRQ)
$92M
P/E
-1.1
EPS
$-1.18
ROE
-216.6%
52W Range
$1–$3
BMEA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-1.182020-12-31 → 2025-12-31
Free Cash Flow·2021-12-31 → 2024-12-31
Net margin-3326.0%2025-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | BMEA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -1.15Y avg ≈-2.7 | ≈-2.7 | · | · | |
| P/B (MRQ) | 7.65Y avg ≈2.5 | ≈2.5 | 1.7 | Overvalued | |
| Price / Cash Flow | -1.35Y avg ≈-3.6 | ≈-3.6 | · | · | |
| Price / Tangible Book | 3.15Y avg ≈2.5 | ≈2.5 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | BMEA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin | -4494.7% | · | -2375.5% | Below avg | |
| EBITDA Margin | -4494.7% | · | -2375.5% | Below avg | |
| Net Profit Margin | -3326.0% | · | -1689.0% | Below avg | |
| ROA | -89.2%5Y avg ≈-69.0% | ≈-69.0% | -31.6% | Weak | |
| ROE | -216.6%5Y avg ≈-117.6% | ≈-117.6% | -61.2% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | BMEA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 3.55Y avg ≈12.1 | ≈12.1 | 4.1 | Below avg | |
| Quick Ratio | 5.05Y avg ≈11.8 | ≈11.8 | 3.3 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | BMEA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -67.1% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | BMEA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | Top tier |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
38.6%
Next Report
Nov 02, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 3, 2026 | $-0.12 | $-0.23 | 47.4% |
| March 31, 2026 | $-0.17 | $-0.24 | 29.8% | |
| Dec. 31, 2025 | $0.27 | $-0.26 | 205.3% | |
| Sept. 30, 2025 | $-0.27 | $-0.26 | -3.5% | |
| June 30, 2025 | $-0.51 | $-0.54 | 5.8% | |
| March 31, 2025 | $-0.80 | $-0.62 | -28.2% | |
| Dec. 31, 2024 | $-0.81 | $-0.94 | 13.8% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $62M | $118M | $103M | $63M | $28M | $4M | |
| SG&A Expense | $19M | $26M | $24M | $21M | $14M | $2M | |
| Operating Expenses | $84M | $144M | $126M | $84M | $42M | $5M | |
| Operating Income | $-84M | $-144M | $-126M | $-84M | $-42M | $-5M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-62M | $-138M | $-117M | $-82M | $-42M | $-5M | |
| EPS (Basic) | $-1.18 | $-3.83 | $-3.44 | $-2.80 | $-1.74 | $-0.51 | |
| EPS (Diluted) | $-1.18 | $-3.83 | $-3.44 | $-2.80 | $-1.74 | $-0.51 | |
| Shares (Basic) | 52,228,068 | 36,105,671 | 34,106,923 | 29,271,777 | 23,858,552 | 10,532,942 | |
| Shares (Diluted) | 52,228,068 | 36,105,671 | 34,106,923 | 29,271,777 | 23,858,552 | 10,532,942 | |
| EBITDA | $-84M | $-144M | $-126M | $-84M | $-42M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $56M | $58M | $177M | $112M | $146M | $62M | |
| Short-term Investments | · | · | · | $1M | $28M | · | |
| Receivables | · | · | · | · | · | $16.0K | |
| Prepaid Expense | $2M | $10M | $2M | $5M | $3M | $528.0K | |
| Other Current Assets | · | · | · | · | · | $29.0K | |
| Current Assets | $58M | $68M | $179M | $118M | $177M | $62M | |
| PP&E (Net) | $153.0K | $4M | $5M | $6M | $3M | $81.0K | |
| PP&E (Gross) | $1M | $8M | $8M | $7M | $3M | $89.0K | |
| Accum. Depreciation | $1M | $4M | $2M | $916.0K | $257.0K | $8.0K | |
| Other Non-current Assets | $0 | $619.0K | $6M | $3M | $1M | $12.0K | |
| Total Assets | $59M | $80M | $200M | $129M | $186M | $63M | |
| Accounts Payable | $3M | $13M | $7M | $7M | $1M | $727.0K | |
| Accrued Liabilities | · | · | · | · | · | $633.0K | |
| Current Liabilities | $11M | $22M | $23M | $19M | $5M | $2M | |
| Capital Leases | $128.0K | $7M | $8M | $2M | $2M | · | |
| Total Liabilities | $29M | $28M | $31M | $21M | $7M | $2M | |
| Common Stock | $7.0K | $4.0K | $4.0K | $3.0K | $3.0K | $1.0K | |
| Paid-in Capital | $479M | $439M | $418M | $240M | $229M | $13M | |
| Retained Earnings | $-449M | $-387M | $-249M | $-132M | $-50M | $-8M | |
| AOCI | · | · | · | $-1.0K | $-10.0K | · | |
| Stockholders' Equity | $30M | $52M | $169M | $109M | $179M | $5M | |
| Liabilities + Equity | $59M | $80M | $200M | $129M | $186M | $63M | |
| Shares Outstanding | 72,299,440 | 36,310,713 | 35,866,610 | 29,561,554 | 29,115,421 | 11,953,107 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $10M | $19M | $14M | $10M | $6M | $322.0K | |
| Operating Cash Flow | $-70M | $-120M | $-97M | $-62M | $-35M | $-4M | |
| CapEx | · | $362.0K | $3M | $1M | $3M | $51.0K | |
| Investing Cash Flow | · | $-362.0K | $-2M | $27M | $-33M | $-51.0K | |
| Stock Issued | $5M | · | $162M | · | · | $10M | |
| Net Stock Activity | $5M | · | $162M | · | · | · | |
| Financing Cash Flow | $68M | $2M | $164M | $1M | $153M | $66M | |
| Net Change in Cash | $-2M | $-119M | $65M | $-34M | $84M | $61M | |
| Free Cash Flow | · | $-120M | $-100M | $-63M | $-39M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -4494.7% | · | · | · | · | · | |
| Net Margin | -3326.0% | · | · | · | · | · | |
| EBITDA Margin | -4494.7% | · | · | · | · | · | |
| ROA | -89.2% | -98.9% | -71.2% | -51.9% | -33.5% | · | |
| ROE | -216.6% | -217.1% | -63.6% | -68.4% | -22.5% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.2 | 3.2 | 7.8 | 6.2 | 38.1 | · | |
| Quick Ratio | 5.0 | 2.7 | 7.7 | 5.9 | 37.4 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.41 | $1.42 | $4.72 | $3.67 | $6.14 | · | |
| Revenue / Share | $0.04 | · | · | · | · | · | |
| Cash Flow / Share | $-1.35 | $-3.32 | $-2.83 | $-2.13 | · | · | |
| Cash / Share | $0.77 | $1.60 | $4.93 | $3.79 | $5.01 | · | |
| EPS (TTM) | $-1.18 | $-3.83 | $-3.44 | $-2.80 | $-1.74 | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -67.1% | -36.4% | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-62M | $-138M | $-117M | $-82M | $-42M | · | |
| Market Cap | $90M | $141M | $521M | $249M | $217M | · | |
| P/E | -1.1 | -1.0 | -4.2 | -3.0 | -4.3 | · | |
| P/B | 3.0 | 2.7 | 3.1 | 2.3 | 1.2 | · | |
| P / Tangible Book | 3.0 | 2.7 | 3.1 | 2.3 | 1.2 | · | |
| P / Cash Flow | -1.3 | -1.2 | -5.4 | -4.0 | -6.1 | · | |
| P / FCF | · | -1.2 | -5.2 | -3.9 | -5.6 | · | |
| Earnings Yield | -95.2% | -98.7% | -23.7% | -33.2% | -23.4% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $165M | |
| R&D Expense | $9M | $9M | $8M | $14M | $17M | $23M | $25M | $27M | $32M | $34M | $31M | $25M | $22M | $24M | $21M | $18M | |
| SG&A Expense | $4M | $4M | $4M | $4M | $5M | $7M | $5M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $5M | |
| Operating Expenses | $13M | $13M | $12M | $21M | $21M | $30M | $30M | $34M | $39M | $41M | $37M | $31M | $28M | $30M | $26M | $23M | |
| Operating Income | $-13M | $-13M | $-12M | $-21M | $-21M | $-30M | $-30M | $-34M | $-39M | $-41M | $-37M | $-31M | $-28M | $-30M | $-26M | $-23M | |
| Net Income | $-8M | $-12M | $5M | $-16M | $-21M | $-29M | $-29M | $-33M | $-37M | $-39M | $-35M | $-28M | $-25M | $-29M | $-25M | $-23M | |
| EPS (Basic) | $-0.12 | $-0.17 | $0.40 | $-0.27 | $-0.51 | $-0.80 | $-0.80 | $-0.91 | $-1.03 | $-1.09 | $-0.96 | $-0.80 | $-0.70 | $-0.98 | $-0.87 | $-0.78 | |
| EPS (Diluted) | $-0.12 | $-0.17 | $0.40 | $-0.27 | $-0.51 | $-0.80 | $-0.80 | $-0.91 | $-1.03 | $-1.09 | $-0.96 | $-0.80 | $-0.70 | $-0.98 | $-0.87 | $-0.78 | |
| Shares (Basic) | 72,360,235 | 72,299,440 | · | 59,848,325 | 40,630,403 | 36,627,148 | 36,265,001 | 36,220,736 | 36,043,561 | 35,890,370 | 35,754,165 | 35,653,988 | 35,348,293 | 29,586,468 | 29,441,596 | 29,319,042 | |
| Shares (Diluted) | 72,360,235 | 72,299,440 | · | 59,848,325 | 40,630,403 | 36,627,148 | 36,265,001 | 36,220,736 | 36,043,561 | 35,890,370 | 35,754,165 | 35,653,988 | 35,348,293 | 29,586,468 | 29,441,596 | 29,319,042 | |
| EBITDA | $-13M | $-13M | · | $-21M | $-21M | $-30M | · | $-34M | $-39M | $-41M | · | $-31M | $-28M | $-30M | · | $-23M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $35M | $45M | $56M | $47M | $56M | $36M | $58M | $88M | $113M | $145M | $177M | $199M | $223M | $86M | $112M | $132M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Prepaid Expense | $1M | $1M | $2M | $3M | $8M | $9M | $10M | $6M | $3M | $3M | · | $3M | $3M | $3M | · | $5M | |
| Current Assets | $36M | $46M | $58M | $49M | $65M | $45M | $68M | $94M | $116M | $148M | · | $203M | $226M | $89M | · | $139M | |
| PP&E (Net) | $47.0K | $67.0K | $153.0K | $200.0K | $3M | $3M | $4M | $4M | $4M | $5M | · | $6M | $6M | $6M | · | $3M | |
| PP&E (Gross) | · | $668.0K | $1M | $1M | $8M | $8M | $8M | $8M | $8M | $8M | · | $8M | $8M | $8M | · | $4M | |
| Accum. Depreciation | · | $601.0K | $1M | $962.0K | $5M | $5M | $4M | $4M | $3M | $3M | · | $2M | $2M | $1M | · | $733.0K | |
| Other Non-current Assets | $398.0K | · | $0 | $0 | $4.0K | $617.0K | $619.0K | $5M | $7M | $7M | · | $5M | $4M | $4M | · | · | |
| Total Assets | $37M | $46M | $59M | $55M | $73M | $55M | $80M | $110M | $136M | $168M | · | $225M | $249M | $113M | · | $145M | |
| Accounts Payable | $3M | $5M | $3M | $6M | $8M | $8M | $13M | $9M | $6M | $5M | · | $3M | $4M | $5M | · | $2M | |
| Current Liabilities | $10M | $9M | $11M | $16M | $18M | $20M | $22M | $28M | $25M | $25M | · | $16M | $14M | $19M | · | $13M | |
| Capital Leases | $0 | $0 | $128.0K | $6M | $6M | $7M | $7M | $7M | $7M | $8M | · | $9M | $10M | $11M | · | $2M | |
| Total Liabilities | $25M | $28M | $29M | $40M | $46M | $26M | $28M | $34M | $32M | $33M | · | $25M | $24M | $30M | · | $14M | |
| Common Stock | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | · | $4.0K | $4.0K | $3.0K | · | $3.0K | |
| Paid-in Capital | $482M | $480M | $479M | $469M | $465M | $445M | $439M | $434M | $429M | $423M | · | $414M | $410M | $244M | · | $237M | |
| Retained Earnings | $-470M | $-461M | $-449M | $-454M | $-437M | $-417M | $-387M | $-358M | $-325M | $-288M | · | $-214M | $-186M | $-161M | · | $-106M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-13.0K | |
| Stockholders' Equity | $12M | $19M | $30M | $16M | $28M | $29M | $52M | $76M | $104M | $135M | $169M | $200M | $224M | $83M | $109M | $131M | |
| Liabilities + Equity | $37M | $46M | $59M | $55M | $73M | $55M | $80M | $110M | $136M | $168M | · | $225M | $249M | $113M | · | $145M | |
| Shares Outstanding | 72,483,852 | 72,299,440 | 72,299,440 | 59,508,518 | 58,127,256 | 37,572,250 | 36,310,713 | 36,238,280 | 36,184,485 | 35,933,586 | · | 35,698,847 | 35,630,276 | 29,651,134 | · | 29,388,753 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $5M | $5M | $5M | $4M | $4M | $3M | $3M | $3M | $3M | |
| Operating Cash Flow | $-10M | $-12M | $-14M | $-12M | $-19M | $-26M | $-30M | $-25M | $-33M | $-32M | $-23M | $-24M | $-26M | $-24M | $-20M | $-17M | |
| CapEx | · | · | · | $0 | $0 | $0 | $82.0K | $186.0K | $59.0K | $35.0K | $8.0K | $39.0K | $417.0K | $3M | $712.0K | $-50.0K | |
| Investing Cash Flow | $0 | $550.0K | · | $0 | $0 | $0 | $-82.0K | $-186.0K | $-59.0K | $-35.0K | $-8.0K | $-39.0K | $-417.0K | $-2M | $-701.0K | $225.0K | |
| Stock Issued | · | · | $-124.0K | $0 | $2M | $3M | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $3M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | · | · | $23M | $2M | $40M | $3M | $413.0K | $69.0K | $1M | $116.0K | $622.0K | $138.0K | $163M | $201.0K | $490.0K | $400.0K | |
| Net Change in Cash | $-10M | $-11M | $9M | $-10M | $20M | $-22M | $-30M | $-25M | $-32M | $-32M | $-22M | $-24M | $137M | $-26M | $-20M | $-16M | |
| Free Cash Flow | · | · | · | · | · | $-26M | · | · | · | $-32M | · | · | · | $-27M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -4001.9% | -2970.7% | · | -473.1% | -3969.4% | -6602.7% | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -2610.7% | -2887.2% | · | -373.1% | -3869.4% | -6502.7% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -4001.9% | -2970.7% | · | -473.1% | -3969.4% | -6602.7% | · | · | · | · | · | · | · | · | · | · | |
| ROA | -15.1% | -24.5% | · | -19.8% | -19.8% | -26.2% | · | -19.5% | -19.4% | -27.8% | · | -15.4% | -12.1% | -20.2% | · | -13.3% | |
| ROE | -42.0% | -52.3% | · | -35.8% | -31.6% | -35.7% | · | -23.8% | -22.7% | -35.8% | · | -17.2% | -13.3% | -23.4% | · | -14.2% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 5.0 | · | 3.2 | 3.7 | 2.3 | · | 3.4 | 4.6 | 5.8 | · | 12.5 | 15.7 | 4.7 | · | 11.0 | |
| Quick Ratio | 3.3 | 4.8 | · | 3.0 | 3.2 | 1.8 | · | 3.2 | 4.5 | 5.7 | · | 12.3 | 15.5 | 4.6 | · | 10.6 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.17 | $0.26 | · | $0.26 | $0.47 | $0.76 | · | $2.10 | $2.87 | $3.77 | · | $5.59 | $6.30 | $2.80 | · | $4.45 | |
| Revenue / Share | $0.00 | $0.01 | · | $0.07 | $0.01 | $0.01 | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.16 | · | · | · | $-0.70 | · | · | · | $-0.89 | · | · | · | $-0.81 | · | · | |
| Cash / Share | $0.48 | $0.62 | · | $0.78 | $0.97 | $0.95 | · | $2.43 | $3.13 | $4.03 | · | $5.58 | $6.26 | $2.91 | · | $4.50 | |
| EPS (TTM) | $-0.16 | $-0.55 | · | $-2.38 | $-3.02 | $-3.54 | · | $-3.99 | $-3.88 | $-3.55 | · | $-3.35 | $-3.33 | $-3.22 | · | $-2.46 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-33M | $-45M | · | $-96M | $-112M | $-129M | · | $-144M | $-140M | $-127M | · | $-108M | $-102M | $-95M | · | $-71M | |
| Market Cap | $107M | $111M | · | $120M | $105M | $80M | · | $366M | $163M | $537M | · | $491M | $782M | $919M | · | $287M | |
| P/E | -9.2 | -2.8 | · | -0.8 | -0.6 | -0.6 | · | -2.5 | -1.2 | -4.2 | · | -4.1 | -6.6 | -9.6 | · | -4.0 | |
| P/B | 8.8 | 5.9 | · | 7.7 | 3.8 | 2.8 | · | 4.8 | 1.6 | 4.0 | · | 2.5 | 3.5 | 11.1 | · | 2.2 | |
| P / Tangible Book | 8.8 | 5.9 | · | 7.7 | 3.8 | 2.8 | · | 4.8 | 1.6 | 4.0 | · | 2.5 | 3.5 | 11.1 | · | 2.2 | |
| P / Cash Flow | · | -9.5 | · | · | · | -3.1 | · | · | · | -16.8 | · | · | · | -38.2 | · | · | |
| Earnings Yield | -10.9% | -35.9% | · | -117.8% | -167.8% | -166.2% | · | -39.5% | -86.2% | -23.8% | · | -24.3% | -15.2% | -10.4% | · | -25.1% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating Margin % | -4494.7% | · | · | · | · |
| Net Income | $-62M | $-138M | $-117M | $-82M | $-42M |
| Diluted EPS | $-1.18 | $-3.83 | $-3.44 | $-2.80 | $-1.74 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 5.2 | 3.2 | 7.8 | 6.2 | 38.1 |
| Quick Ratio | 5.0 | 2.7 | 7.7 | 5.9 | 37.4 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | $-120M | $-100M | $-63M | $-39M |
Institutional owners (13F) 73 filers · $41.7M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
73
Value held
$41.7M
New positions
8
Exited positions
14
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 8 (-9 vs prior Q) | 14 (+6 vs prior Q) | 25 (+6 vs prior Q) | 11 (-3 vs prior Q) | +1.3M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| FMR LLC | $12,957,970 | 8,814,946 | 31.04% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $4,159,993 | 2,829,927 | 9.97% | Shares |
| VANGUARD GROUP INC | $3,680,371 | 2,968,041 | 8.82% | Shares |
| MARSHALL WACE, LLP | $3,013,208 | 2,049,802 | 7.22% | Shares |
| Aisling Capital Management LP | $3,011,673 | 2,048,757 | 7.22% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $2,139,547 | 1,455,474 | 5.13% | Shares |
| FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. | $1,063,069 | 723,176 | 2.55% | Shares |
| BlackRock, Inc. | $1,051,704 | 715,445 | 2.52% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $1,042,477 | 708,854 | 2.50% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $900,720 | 612,735 | 2.16% | Shares |
| Mariner, LLC | $874,247 | 594,726 | 2.09% | Shares |
| JANE STREET GROUP, LLC | $673,685 | 458,289 | 1.61% | Shares |
| UBS Group AG | $653,750 | 444,728 | 1.57% | Shares |
| XTX Topco Ltd | $598,112 | 406,879 | 1.43% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $585,795 | 398,500 | 1.40% | Call option |
| TWO SIGMA INVESTMENTS, LP | $565,155 | 384,459 | 1.35% | Shares |
| MORGAN STANLEY | $539,521 | 367,021 | 1.29% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $497,367 | 338,345 | 1.19% | Shares |
| MAI Capital Management | $424,977 | 289,100 | 1.02% | Shares |
| STATE STREET CORP | $378,253 | 257,315 | 0.91% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $317,226 | 215,800 | 0.76% | Put option |
| CITADEL ADVISORS LLC | $262,101 | 178,300 | 0.63% | Call option |
| LMR Partners LLP | $261,000 | 200,000 | 0.63% | Shares |
| NORTHERN TRUST CORP | $188,933 | 128,526 | 0.45% | Shares |
| JANE STREET GROUP, LLC | $180,810 | 123,000 | 0.43% | Call option |
| Headlands Technologies LLC | $163,683 | 111,349 | 0.39% | Shares |
| Marex Group Ltd | $147,000 | 100,000 | 0.35% | Shares |
| GOLDMAN SACHS GROUP INC | $137,822 | 93,757 | 0.33% | Shares |
| TWO SIGMA ADVISERS, LP | $131,192 | 105,800 | 0.31% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $124,362 | 84,600 | 0.30% | Shares |
| Jain Global LLC | $111,276 | 75,698 | 0.27% | Shares |
| GRIFFIN ASSET MANAGEMENT, INC. | $87,906 | 59,800 | 0.21% | Shares |
| SUPERSTRING CAPITAL MANAGEMENT LP | $85,306 | 250,000 | 0.20% | Shares |
| Graham Capital Management, L.P. | $78,579 | 53,455 | 0.19% | Shares |
| CITADEL ADVISORS LLC | $66,027 | 44,916 | 0.16% | Shares |
| ADAR1 Capital Management, LLC | $63,827 | 43,420 | 0.15% | Shares |
| Rathbones Group PLC | $54,390 | 37,000 | 0.13% | Shares |
| Vanguard Global Advisers, LLC | $50,900 | 34,626 | 0.12% | Shares |
| Point72 Asset Management, L.P. | $48,204 | 32,792 | 0.12% | Shares |
| WOLVERINE TRADING, LLC | $36,462 | 17,700 | 0.09% | Call option |
| PNC Financial Services Group, Inc. | $35,280 | 24,000 | 0.08% | Shares |
| Bank of New York Mellon Corp | $23,184 | 15,771 | 0.06% | Shares |
| CFS Investment Advisory Services, LLC | $22,303 | 15,818 | 0.05% | Shares |
| BIRCH FINANCIAL GROUP, LLC | $20,580 | 14,000 | 0.05% | Shares |
| TWO SIGMA SECURITIES, LLC | $20,545 | 13,976 | 0.05% | Shares |
| Point72 Asia (Singapore) Pte. Ltd. | $20,259 | 10,029 | 0.05% | Shares |
| CITADEL ADVISORS LLC | $19,404 | 13,200 | 0.05% | Put option |
| Qube Research & Technologies Ltd | $18,668 | 12,699 | 0.04% | Shares |
| NewEdge Advisors, LLC | $17,640 | 12,000 | 0.04% | Shares |
| Creative Planning | $17,640 | 12,000 | 0.04% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare GP III, LLC, Cormorant Asset Management, LP, Chen Bihua ×5 filings | Oct. 24, 2025 | 1.53% | Amendment | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 12 insiders · 5 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Michael J.M. Hitchcock | Interim CEO | April 1, 2026 A | 115,000 | 1 | 0 | $99,000 |
| Thomas Andrew Butler | Chief Executive Officer | Jan. 17, 2024 A | 228,470 | 0 | 0 | $0 |
| Franco Valle | Chief Financial Officer | Nov. 30, 2024 A | 42,995 | 0 | 0 | $0 |
| Rainer M Erdtmann | President, Chief Operating Officer, Principal Financial Officer, and Principal Accounting Officer | April 1, 2026 A | 723,027 | 3 | 0 | $97,400 |
| Juan Pablo Frias | Chief Medical Officer | May 31, 2024 A | 349 | 0 | 0 | $0 |
| Julianne Averill | Director | June 10, 2026 A | · | 0 | 0 | $0 |
| Sumita Ray | Director | June 10, 2026 A | · | 0 | 0 | $0 |
| Elizabeth Faust | Director | June 10, 2026 A | · | 0 | 0 | $0 |
| Eric Aguiar | Director | June 10, 2026 A | · | 0 | 0 | $0 |
| Sotirios Stergiopoulos | Director | Sept. 17, 2021 P | 4,400,000 | 0 | 0 | $0 |
| A2A Pharmaceuticals, Inc. | 10% owner | June 1, 2023 S | 3,500,000 | 0 | 0 | $0 |
| Biomea Health, LLC | 10% owner | June 1, 2022 J | 0 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
BMEA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 13 analysts
BUY
Median target
$7.00
+451.2%
5 38.5%
Strong Buy
6 46.2%
Buy
1 7.7%
Hold
1 7.7%
Sell
0 0.0%
Strong Sell
12-Month Price Target
6 analysts · 2026-09-29Mean target $6.50 +411.8%
← Below all targets
Current price $1.27
Low$4.00
Mean$6.50
High$9.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| BMEA | $90M | -1.1 | -67.1% | -3326.0% | -216.6% | · |
| OKUR | · | -0.7 | · | -1733.7% | -88.6% | · |
| ANIX | $136M | -12.1 | 0.00% | · | -62.2% | · |
| EQ | $95M | -4.0 | 13.9% | · | -133.1% | · |
| CRDF | $192M | -4.1 | -13.2% | -7732.0% | -88.2% | · |
| CTOR | $170M | -6.0 | · | · | -61.5% | · |
| CNXU | · | · | · | · | · | · |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | · |
| MNOV | $64M | -5.5 | · | -2928.8% | -27.1% | · |
| ICCC | · | -51.2 | 4.3% | · | · | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 5, 2026